rolipram and atl 146e
rolipram has been researched along with atl 146e in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Huang, L; Linden, J; Okusa, MD; Rosin, DL; Smith, DF; Sullivan, G | 1 |
| Beller, GA; Glover, DK; Linden, J; Macdonald, TL; Rieger, JM; Riou, LM; Ruiz, M; Sullivan, GW; Watson, DD | 1 |
| Lappas, CM; Linden, J; Rieger, JM | 1 |
| Chevalier, RL; Forbes, MS; Lange-Sperandio, B; Linden, J; Okusa, MD; Thornhill, B | 1 |
Other Studies
4 other study(ies) available for rolipram and atl 146e
| Article | Year |
|---|---|
Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Kidney Injury; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Mice; Mice, Inbred C57BL; Neutrophils; Peroxidase; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purines; Reactive Oxygen Species; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reperfusion Injury; Respiratory Burst; Rolipram | 2001 |
Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine A2 Receptor Agonists; Animals; Cardiotonic Agents; Coronary Circulation; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dogs; Drug Therapy, Combination; Myocardial Infarction; Myocardial Reperfusion Injury; Myocarditis; Phosphodiesterase Inhibitors; Purines; Respiratory Burst; Rolipram | 2005 |
A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; CD4-Positive T-Lymphocytes; Cell Line; Cyclic AMP; Cyclohexanecarboxylic Acids; Gene Dosage; Humans; Interferon-gamma; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Purines; Receptor, Adenosine A2A; Receptors, Antigen, T-Cell; RNA, Messenger; Rolipram; Triazines; Triazoles | 2005 |
A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Apoptosis; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Fibrosis; Inflammation; Kidney Diseases; Mice; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Purines; Receptors, Adenosine A2; Rolipram; Ureteral Obstruction | 2005 |